ARTICLES BY ERIC LARSON
Medtech Material Selection For Performance And Feel
When designing a medical device, material selection can be difficult, especially with thousands of plastic material options available. While material properties, environmental effects, regulatory requirements, and cost almost always are considered, "feel" is often overlooked – despite its importance to user and patient satisfaction, as well as market success.
Continue Reading..
Medical Plastics: Material Selection Based On Feel
From prioritizing material properties to establishing desired values for each property, selecting plastic materials based on feel is a complicated undertaking. To elicit the most desirable user response from the device, it can be helpful to consider the what, rather than the how.
Continue Reading..
06.23.26 -- CQV In The Digital Age: Adapting Validation For Agile Manufacturing
06/23/26 Med Device Online Newsletter
Continue Reading..
Does The FDA's Plausible Mechanism Pathway Revolutionize The Way All Risks Are Analyzed?
The FDA's new guidance on plausible mechanisms represents the first regulatory guidance-driven example of where the primary information source of a risk analysis is shifted from data-based to mechanism-based evidence.
Continue Reading..
06.21.26 -- QMSR Opens The Door To LATAM's Medtech Trial Edge
06/21/26 Med Device Online Newsletter
Continue Reading..
Tissues And Complex Materials Why Toxicology-Chemistry Collaboration Matters
Gain practical insights into overcoming the challenges of complex material characterization through effective collaboration between chemistry and toxicology to support robust regulatory and risk assessment strategies.
Continue Reading..
Hormuz Deal Brings Cautious Relief To Pharma Packaging Supply Chains
Restrictions and fear on the Hormuz Strait have fractured supply chains, especially for primary materials used in pharmaceutical packaging.
Continue Reading..
06.18.26 -- Inside FDA's First 100 QMSR Inspections
06/18/26 Med Device Online Newsletter
Continue Reading..
Why Your LATAM Authorized Representative Strategy Is A Market Entry Decision, Not A Clerical One
Across Latin American medical device markets, the local authorized representative that holds or manages the regulatory asset becomes the operational choke point for importation, renewals, and more.
Continue Reading..
The Mold Is Only Half The Story
In micro molding, automation isn’t an add-on. Learn how integrated handling, inspection, and packaging enable scalable, high-quality production.
Continue Reading..